Drug Delivery Business

Abbott unveils new Libre app feature for mealtime decisions

Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).
Fierce Biotech

Abbott launches AI-based Libre Assist, its new in-app feature for meal planning

Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...

Abbott's FreeStyle Libre 3 Plus Now Covered Across Canada

Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...
TMCnet

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Libre Assist 1 uses generative AI to predict how a food choice may affect a person's glucose levels. 2 It then offers ...
Cantech Letter

Health Canada approves expanded compatibility for mylife Loop with iOS and Abbott’s FreeStyle Libre 3 Plus Sensor

Loop powered by mylife CamAPS FX becomes the first automated insulin delivery system in Canada compatible with two glucose monitoring systems for people living with type 1 diabetes ...